Labcorp Holdings Inc.

Labcorp Holdings Inc. is a leading healthcare company that provides comprehensive laboratory services. Its business is organized into two main segments: Diagnostics Laboratories and Biopharma Laboratory Services. The company offers a wide range of tests including blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures, and alcohol and substance abuse tests. It also provides specialty testing services such as gene-based and esoteric testing, advanced tests for specific diseases, and services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing, medical drug monitoring, chronic disease programs, and kidney stone prevention tests. Additionally, Labcorp offers health and wellness services to employers and managed care organizations, digital pathology solutions, and provider and payer digital platforms.

Labcorp Holdings Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol LH. Its shares are traded in US Dollars (USD). The company is headquartered in the United States and operates primarily in the US market, though its services have a broad reach.

Labcorp Holdings Inc. operates in the Healthcare sector, specifically within the Diagnostics & Research industry. This means the company is involved in providing diagnostic testing services and research support to healthcare providers, pharmaceutical companies, and other clients. Its work is critical for disease detection, treatment monitoring, and drug development.

Labcorp offers a variety of advanced testing services and digital solutions. Its portfolio includes tests for specific diseases, anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and more. The company also provides digital pathology platforms that support digitization and centralized review of pathology slides. For patients and providers, Labcorp offers online and mobile applications that enable appointment scheduling, check-in, documentation, test result access, and account management. Additionally, it has a Generative AI-enabled Test Selection tool that assists in choosing appropriate tests. These digital tools enhance convenience and efficiency for healthcare providers and patients.

Labcorp serves a diverse range of clients including individual patients, healthcare providers, third-party payers, managed care organizations (MCOs), accountable care organizations (ACOs), employers, and government programs like Medicare and Medicaid. The company provides laboratory testing services through its Diagnostics Laboratories segment, which handles routine and specialty tests, and its Biopharma Laboratory Services segment, which supports pharmaceutical and biotechnology companies in drug development. Labcorp also offers health and wellness programs to employers and managed care organizations, helping them manage population health. Its digital platforms facilitate seamless interactions for providers and patients, making it easier to order tests, receive results, and manage accounts.